• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Easy Document Access Key to Inspection Success, Expert Says

Easy Document Access Key to Inspection Success, Expert Says

July 29, 2019
Leslie Ramsey

When the FDA shows up with inspection notice in hand, will you be able to produce the documents they request quickly and efficiently? Knowing where all your records are stored and what condition they are in is vital to inspection success, says one former FDA district director.

Even though “clinical trial monitoring records are sort of like ‘mini audits’,” says quality consultant and 23-year FDA veteran David Chesney, sites still are subject to FDA inspection.

Chesney offers several tips for making sure records the FDA wants to see are labeled, stored, archived and easily accessible during an inspection.

Start with a consistent naming convention that is unique but succinct. File names in electronic systems often are cut short, so document titles should be identifiable by only a few words or numeric designation. And whatever convention you use, train the staff that will retrieve documents to recognize them quickly.

Archived documents should be held in easily accessed locations or designated drives, in the case of electronic records, which also should have controls over reading, copying and printing.

Inventory documents by owner, Chesney advises, and periodically reconcile that inventory to make sure documents are present. And develop both a written retrieval plan and a written strategy for processing inspection requests. It’s helpful, he says, to create a document matrix that shows the assigned document owners for each type of record likely to be requested.

For clues on what documents the FDA is likely to request, consult the FDA’s Compliance Program 7348.810, which provides agency personnel with instructions for conducting inspections.

“The challenge,” Chesney says, “is to meet the FDA requests in a timely and complete manner.” To evaluate your ability to do that, he suggests asking the following 10 questions:

  1. Do your archives contain everything that may be requested during an inspection?
  2. Are file names clear (ideally self-explanatory)?
  3. Are there written requirements for in-house, remote or contracted employees and third-party vendors to transfer materials into the archives?
  4. Do the archives contain more than one original and, if so, how are they differentiated?
  5. Do the archives contain draft documents and, if so, how are they differentiated from final versions?
  6. If archiving has been contracted to a third party, does the contract allow for prompt access for the records owner?
  7. Are records produced by other parties for your company readily accessible (for example, CROs, contractors, consultants)?
  8. Can documents be retrieved in a prompt and effective manner?
  9. Have the access security measures associated with the archives been tested?
  10. Do personnel responsible for the archives have the access and resources needed to produce documents during an inspection?

Chesney recommends testing document retrieval capabilities during mock inspections and internal audits, tracking how long it takes to properly fulfill a document request and working to improve that response time.

Finally, make sure to assign and train personnel who have first-hand knowledge of the documents to explain them during an inspection.

Read Compliance Program 7348.810 here: https://bit.ly/2YqimR5.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing